News EPFL

Appointment of EPFL professors

Published:12.03.22 — The Board of the Swiss Federal Institutes of Technology has announced the appointment of professors at EPFL.

Connecting stress, weight, and social anxiety in early adolescence

Published:10.03.22 — Scientists at EPFL have found a biological connection explaining why there is an increased predisposition to develop obesity and being less sociable in individuals that have experienced stress during early puberty.

New research program will study fjord ecosystems in Greenland

Published:09.03.22 — In a four-year field research program led by EPFL, in association with several other Swiss institutions, scientists will aim to understand the ecosystem of Greenlandic fjords in the context of a changing climate. They plan to investigate how accelerated glacier discharge and soil erosion impact the fjords nutrient cycle, marine resources and cloud formation, and how local livelihoods are affected.

Seven distinguished women scientists get their place on the EPFL map

Published:08.03.22 — To mark International Women’s Day on 8 March, EPFL officially named squares and streets on its Lausanne campus after pioneering women in scientific and engineering fields.

Girl Power: Can we Break the Bias in Al and Beyond?

Published:08.03.22 — We all know the story. It gets rolled out every March when women and men around the world celebrate International Women’s Day. Human biases are well documented, from the implicit to the explicit and they have always existed but as algorithms and big data increasingly run our lives these biases become embedded in everything.

In conversation about privacy: Chelsea Manning and Carmela Troncoso

Published:04.03.22 — Former US army intelligence analyst, Chelsea Manning and EPFL Professor Carmela Troncoso, will be in conversation at EPFL’s Rolex Learning Center next Monday for an exclusive, live discussion, open to the public and streamed, on privacy and data security for the public good.

EPFL spin-off develops protein to boost immunotherapy

Published:04.03.22 — EPFL spin-off Leman Biotech has developed a protein that can improve the effectiveness of immunotherapy drugs used to treat some types of cancer. The firm has just completed its first funding round, in the amount of $11 million.